OpenAlex
PricingAboutJobs
Log inGet started
Work

Effects of monoclonal antibodies against amyloid-β on clinical and biomarker outcomes and adverse event risks: A systematic review and meta-analysis of phase III RCTs in Alzheimer’s disease

HTML

Year: 2021
Type: review
Study designs: Systematic Review, Meta-Analysis
Source: Ageing Research Reviews
DOI: 10.1016/j.arr.2021.101339
Authors: Konstantinos I. Avgerinos, Luigi Ferrucci, Dimitrios Kapogiannis
Institutions: National Institutes of Health, National Institute on Aging
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: monoclonal antibodies, amyloid-beta, Alzheimer's disease, amyloid PET, amyloid-related imaging abnormalities, cognitive outcomes, functional outcome, cerebrospinal fluid biomarkers, tau protein, aducanumab, solanezumab, bapineuzumab, gantenerumab, crenezumab, adverse events
SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute on Aging
Awards: G7423759087, ALZHEIMERS RESEARCH PROJECT / CLINICAL PROJECT: Mechanistic and clinical studies in Alzheimer's disease and related disorders
OpenAlex ID: W3146410983
FWCI: 5.138
Cites: 46
Cited by: 260
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security